(S (NP (JJ Adverse) (NN drug) (NN reaction) (PRN (-LRB- -LRB-) (NP (NN ADR)) (-RRB- -RRB-))) (VP (VBZ is) (ADJP (RB widely) (JJ concerned) (PP (IN for) (NP (NML (JJ public) (NN health)) (NN issue))))) (. .))
(S (NP (NNS ADRs)) (VP (VBP are) (NP (NP (CD one)) (PP (IN of) (NP (JJS most) (JJ common) (NNS causes))) (S (VP (TO to) (VP (VB withdraw) (NP (DT some) (NNS drugs)) (PP (IN from) (NP (NN market)))))))) (. .))
(S (NP (NML (NN Prescription) (NN event)) (NN monitoring) (PRN (-LRB- -LRB-) (NP (NN PEM)) (-RRB- -RRB-))) (VP (VBZ is) (NP (DT an) (JJ important) (NN approach) (S (VP (TO to) (VP (VB detect) (NP (DT the) (JJ adverse) (NN drug) (NNS reactions))))))) (. .))
(S (NP (DT The) (JJ main) (NN problem) (S (VP (TO to) (VP (VB deal) (PP (IN with) (NP (DT this) (NN method))))))) (VP (VBZ is) (SBAR (WHADVP (WRB how)) (S (VP (TO to) (ADVP (RB automatically)) (VP (VB extract) (NP (NP (DT the) (JJ medical) (NNS events)) (CC or) (NP (NN side) (NNS effects))) (PP (IN from) (NP (NP (NML (JJ high) (HYPH -) (NN throughput)) (JJ medical) (NNS data)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (VP (VBN collected) (PP (IN from) (NP (NN day))) (PP (IN to) (NP (NN day) (JJ clinical) (NN practice)))))))))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN study))) (NP (PRP we)) (VP (VBP propose) (NP (DT an) (JJ original) (NN approach)) (S (VP (TO to) (VP (VB detect) (NP (DT the) (NNS ADRs)) (S (VP (VBG using) (NP (NP (NN feature) (NN matrix)) (CC and) (NP (NN feature) (NN selection))))))))) (. .))
(S (NP (DT The) (NNS experiments)) (VP (VBP are) (VP (VBN carried) (PRT (RP out)) (PP (IN on) (NP (DT the) (NN drug) (NNP Pravastatin))))) (. .))
(S (NP (NP (JJ Major) (NN side) (NNS effects)) (PP (IN for) (NP (DT the) (NN drug)))) (VP (VBP are) (VP (VBN detected))) (. .))
(S (S (NP (DT The) (VBN detected) (NNS ADRs)) (VP (VBP are) (VP (VBN based) (PP (IN on) (NP (JJ computerized) (NN method)))))) (, ,) (NP (JJ further) (NN investigation)) (VP (VBZ is) (VP (VBN needed))) (. .))
